Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial

Radchenko, Sirenko, Kushnir, Torbas, Dobrohod
  • Vascular Health and Risk Management, September 2013, Dove Medical Press
  • DOI: 10.2147/vhrm.s44568
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Professor Yuriy M. Sirenko and Dr Ganna D Radchenko